{"id":2496,"date":"2022-05-24T16:19:00","date_gmt":"2022-05-24T08:19:00","guid":{"rendered":"https:\/\/medicine.nus.edu.sg\/csa\/?post_type=tribe_events&#038;p=2496"},"modified":"2022-06-15T00:49:02","modified_gmt":"2022-06-14T16:49:02","slug":"hipscs-101","status":"publish","type":"tribe_events","link":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/","title":{"rendered":"hiPSCs 101"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" class=\"size-medium wp-image-2498 alignleft\" src=\"https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image-170x300.png\" alt=\"\" width=\"170\" height=\"300\" srcset=\"https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image-170x300.png 170w, https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image-580x1024.png 580w, https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image-768x1355.png 768w, https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image-871x1536.png 871w, https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image-1161x2048.png 1161w, https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/image.png 1729w\" sizes=\"(max-width: 170px) 100vw, 170px\" \/><\/p>\n<p>Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy.<\/p>\n<p>Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian..<\/p>\n","protected":false},"author":9195,"featured_media":2559,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[],"tribe_events_cat":[34],"class_list":["post-2496","tribe_events","type-tribe_events","status-publish","has-post-thumbnail","hentry","tribe_events_cat-lecture","cat_lecture"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>hiPSCs 101 - NUHS CS Academy<\/title>\n<meta name=\"description\" content=\"Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"hiPSCs 101 - NUHS CS Academy\" \/>\n<meta property=\"og:description\" content=\"Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/\" \/>\n<meta property=\"og:site_name\" content=\"NUHS CS Academy\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-14T16:49:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/2-hiPSCs-101-1-580x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"580\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/\",\"url\":\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/\",\"name\":\"hiPSCs 101 - NUHS CS Academy\",\"isPartOf\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/csa\/#website\"},\"datePublished\":\"2022-05-24T08:19:00+00:00\",\"dateModified\":\"2022-06-14T16:49:02+00:00\",\"description\":\"Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicine.nus.edu.sg\/csa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\/\/medicine.nus.edu.sg\/csa\/events\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"hiPSCs 101\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicine.nus.edu.sg\/csa\/#website\",\"url\":\"https:\/\/medicine.nus.edu.sg\/csa\/\",\"name\":\"NUHS CS Academy\",\"description\":\"Clinician Scientist Academy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicine.nus.edu.sg\/csa\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"hiPSCs 101 - NUHS CS Academy","description":"Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/","og_locale":"en_US","og_type":"article","og_title":"hiPSCs 101 - NUHS CS Academy","og_description":"Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.","og_url":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/","og_site_name":"NUHS CS Academy","article_modified_time":"2022-06-14T16:49:02+00:00","og_image":[{"width":580,"height":1024,"url":"https:\/\/medicine.nus.edu.sg\/csa\/wp-content\/uploads\/sites\/21\/2022\/05\/2-hiPSCs-101-1-580x1024.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/","url":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/","name":"hiPSCs 101 - NUHS CS Academy","isPartOf":{"@id":"https:\/\/medicine.nus.edu.sg\/csa\/#website"},"datePublished":"2022-05-24T08:19:00+00:00","dateModified":"2022-06-14T16:49:02+00:00","description":"Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy. Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.","breadcrumb":{"@id":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicine.nus.edu.sg\/csa\/event\/hipscs-101\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicine.nus.edu.sg\/csa\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/medicine.nus.edu.sg\/csa\/events\/"},{"@type":"ListItem","position":3,"name":"hiPSCs 101"}]},{"@type":"WebSite","@id":"https:\/\/medicine.nus.edu.sg\/csa\/#website","url":"https:\/\/medicine.nus.edu.sg\/csa\/","name":"NUHS CS Academy","description":"Clinician Scientist Academy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicine.nus.edu.sg\/csa\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/tribe_events\/2496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/users\/9195"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/comments?post=2496"}],"version-history":[{"count":5,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/tribe_events\/2496\/revisions"}],"predecessor-version":[{"id":2502,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/tribe_events\/2496\/revisions\/2502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/media\/2559"}],"wp:attachment":[{"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/media?parent=2496"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/tags?post=2496"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/csa\/wp-json\/wp\/v2\/tribe_events_cat?post=2496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}